HCPCS Level II
J9326
Injection, telisotuzumab vedotin-tllv, 1 mg
Codes near J9326
These sit next to J9326 in the CMS Level II file. All J codes
- J9321Injection, epcoritamab-bysp, 0.16 mg
- J9322Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg
- J9323Injection, pemetrexed ditromethamine, 10 mg
- J9324Injection, pemetrexed (pemrydi rtu), 10 mg
- J9325Injection, talimogene laherparepvec, per 1 million plaque forming units
- J9328Injection, temozolomide, 1 mg
- J9329Injection, tislelizumab-jsgr, 1mg
- J9330Injection, temsirolimus, 1 mg
- J9331Injection, sirolimus protein-bound particles, 1 mg
- J9332Injection, efgartigimod alfa-fcab, 2mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00074-1044-01 | Emrelis | AbbVie Inc. | 20 |
| 00074-1055-01 | Emrelis | AbbVie Inc. | 100 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.